Using weighted blankets to reduce anxiety in cancer patients during infusions
Weighted Blanket Use in Oncology Patients to Reduce Anxiety
This study is testing whether using weighted blankets can help reduce anxiety in cancer patients during their first infusion therapy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 114 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ohio State University Comprehensive Cancer Center Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 1 site (Columbus, Ohio) |
| Trial ID | NCT06089408 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the effectiveness of weighted blankets compared to regular blankets in reducing anxiety and distress in oncology patients undergoing their first infusion therapy, such as chemotherapy or targeted therapy. Patients will be randomly assigned to either use a weighted blanket or a standard blanket for 30 minutes during their infusion appointment. The primary objective is to assess the impact of weighted blankets on anxiety levels, while the secondary objective focuses on their effect on overall distress. The study aims to leverage the calming effects of deep touch pressure provided by weighted blankets to enhance patient comfort during treatment.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are about to begin targeted or cytotoxic chemotherapy.
Not a fit: Patients currently using a weighted blanket at home or those with specific medical conditions such as peripheral neuropathy or claustrophobia may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce anxiety and distress in cancer patients during infusion therapies.
How similar studies have performed: While the use of weighted blankets for anxiety is gaining interest, this specific application in oncology settings is relatively novel and has not been extensively tested in similar studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years of age and older * About to begin either targeted or cytotoxic chemotherapy * Able to comprehend and sign a consent form * Able to read and complete surveys * Alert and oriented Exclusion Criteria: * Currently using a weighted blanket at home * Non-English speaking * Peripheral neuropathy * Fibromyalgia * Open pressure ulcer * Recent surgical flap * Claustrophobic * Weight 45 kg or less
Where this trial is running
Columbus, Ohio
- Ohio State University Comprehensive Cancer Center — Columbus, Ohio, United States (Recruiting)
Study contacts
- Principal investigator: Allison De Villiers, MSN, RN, ONC — Ohio State University Comprehensive Cancer Center
- Study coordinator: The Ohio State Comprehensive Cancer Center
- Email: OSUCCCClinicaltrials@osumc.edu
- Phone: 800-293-5066
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.